验证数据展示
经过测试的应用
Positive WB detected in | λ phosphatase treated HeLa cells |
Positive IF/ICC detected in | λ phosphatase treated HeLa cells |
推荐稀释比
应用 | 推荐稀释比 |
---|---|
Western Blot (WB) | WB : 1:1000-1:6000 |
Immunofluorescence (IF)/ICC | IF/ICC : 1:200-1:800 |
It is recommended that this reagent should be titrated in each testing system to obtain optimal results. | |
Sample-dependent, Check data in validation data gallery. |
产品信息
28925-1-AP targets Phospho-PLA2G4A (Ser505) in WB, IF/ICC, ELISA applications and shows reactivity with Human samples.
经测试应用 | WB, IF/ICC, ELISA Application Description |
经测试反应性 | Human |
免疫原 | Peptide 种属同源性预测 |
宿主/亚型 | Rabbit / IgG |
抗体类别 | Polyclonal |
产品类型 | Antibody |
全称 | phospholipase A2, group IVA (cytosolic, calcium-dependent) |
别名 | cPLA2, cPLA2 alpha, Cytosolic phospholipase A2, Phospho-PLA2G4A (Ser505), PLA2G4, PLA2G4A |
计算分子量 | 749 aa, 85 kDa |
观测分子量 | 100-110 kDa |
GenBank蛋白编号 | BC114340 |
基因名称 | PLA2G4A |
Gene ID (NCBI) | 5321 |
RRID | AB_2918213 |
偶联类型 | Unconjugated |
形式 | Liquid |
纯化方式 | Antigen affinity purification |
UNIPROT ID | P47712 |
储存缓冲液 | PBS with 0.02% sodium azide, 50% glycerol, and 0.05% BSA , pH 7.3 |
储存条件 | Store at -20°C. Stable for one year after shipment. Aliquoting is unnecessary for -20oC storage. |
背景介绍
PLA2G4A, also named as cPLA2 (cytosolic phospholipase A2), is a highly conserved and widely expressed enzyme which can promote lipid mediator production. PLA2G4A plays a major role in membrane lipid remodeling and biosynthesis of lipid mediators of the inflammatory response. It has been reported that the activity and expression levels of PLA2G4A are upregulated in several neurodegenerative diseases. PLA2G4A can be activated at the phosphorylation site of ser505 by MAP kinase. (PMID: 25838312, 8381049, 31238788)
实验方案
Product Specific Protocols | |
---|---|
WB protocol for Phospho-PLA2G4A (Ser505) antibody 28925-1-AP | Download protocol |
IF protocol for Phospho-PLA2G4A (Ser505) antibody 28925-1-AP | Download protocol |
Standard Protocols | |
---|---|
Click here to view our Standard Protocols |